Tuesday, June 04, 2019 5:33:55 PM
The posted PR is unrelated to ISCO.
The stem cells used are unrelated to the type ISCO uses.
The procedure is unrelated to the procedure used in ISCO clinical trial.
All the way around, the company in the posted pr and ISCO are unrelated. But, most importantly, unrelated in type of stem cells used.
The stem cells used are unrelated to the type ISCO uses.
The procedure is unrelated to the procedure used in ISCO clinical trial.
All the way around, the company in the posted pr and ISCO are unrelated. But, most importantly, unrelated in type of stem cells used.
To follow KarinCA, click here then click "Follow This Member" under my photo.
Be kinder than necessary, for everyone you meet is fighting some kind of battle.
Recent ISCO News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/14/2026 08:00:37 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/29/2026 08:35:02 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/30/2026 09:29:18 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/18/2025 10:18:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2025 09:00:53 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/16/2025 01:57:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/20/2025 12:21:17 PM
